Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Technical Chemicals and Products, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Technical Chemicals and Products, Inc.: Acquires remaining 20% of Health-Mark Diagnostics, manufacturer of the recently launched HealthCheck line of over-the-counter test kits. The deal makes HMD a wholly owned subsidiary of TCPI, which says it plans to consolidate HMD's Mountain Lakes, New Jersey-based operations into TCPI's facility in Pompano Beach, Florida. HealthCheck products cleared by FDA include kits for pregnancy and ovulation; vision screening and skin growth monitoring. Tests for urine nitrate (urinary tract infections), urine glucose (diabetes), and urine protein (kidney/bladder disorders) "are in the final phase of FDA review and are expected to be released shortly," the firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel